Carol Stonham MBE, RN, MSc, Queen’s Nurse, and Policy Lead PCRS joins the Bedfont® Medical Advisory Board

Bedfont® Scientific Ltd, a leading innovator in breath analysis medical device technology, is proud to announce the addition of Carol Stonham, a highly respected and accredited respiratory healthcare expert, to its esteemed medical board.

PD-L1 Subgroup Benefits Most From Neoadjuvant Immunotherapy in Early Breast Cancer

Promising findings from two clinical trials at the San Antonio Breast Cancer Symposium (SABCS) suggest that adding immunotherapy to chemotherapy in the neoadjuvant setting may

January 10, 2024

The power of the mind in weight loss and long-term success

2024 can easily be dubbed the year of Ozempic, but the negative effects of the now Holywood famous drug can heavily outweigh the positives in

December 23, 2024

Roche is ‘evaluating potential options’ for IPF drug Esbriet as generics gain traction

Roche is looking to offload its idiopathic pulmonary fibrosis drug Esbriet as more patients with the fatal lung disease opt for generic versions and Big

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.